RECURRENT GLIOSARCOMA
Clinical trials for RECURRENT GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in fight against deadly brain cancer
Disease control TerminatedThis study is testing a new two-part treatment for aggressive brain tumors that have returned or worsened. It aims to see if giving the drugs GI-102 and pembrolizumab just before surgery is safe and can help the immune system attack the tumor. The trial is for adults with specifi…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Modified stem cells sent to fight brain cancer
Disease control OngoingThis early-stage study is testing the safety of a new two-part treatment for aggressive brain tumors that have returned after standard therapy. Doctors place genetically modified stem cells directly into the brain during surgery, hoping these cells will make the tumor more sensit…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC